Company: HCTI
Filing Date: 2025-11-19
Form Type: S-3/A
Source: 0001213900-25-112651
Chunk: 31

Company: Healthcare Triangle, Inc.
Filing Date: 2025-11-19
Form: S-3/A
Chunk 31
---
 Florida 33431. The number of shares listed in the third column, which are the shares  
 to be sold in this offering, consist of the shares of Common Stock issuable upon exercise of the Placement Agent Warrants and the Inducement 
 Advisor Warrants. WallachBeth Capital, LLC and its designees acquired the Placement Agent Warrants in the ordinary course of business        
 and, at the time the Placement Agent Warrants and the Inducement Advisor Warrants were acquired, neither WallachBeth Capital, LLC nor        
 its designees had any agreement or understanding, directly or indirectly, with any person to distribute such securities.                     |

<div align='center'>16

DESCRIPTION OF SECURITIES THAT THE
SELLING STOCKHOLDERS ARE OFFERING</div>

The Selling Stockholders are offering for resale
up to an aggregate of 1,458,118 shares of Common Stock. The terms of our shares of Common Stock are contained in our Amended and Restated
Certificate of Incorporation and our amended and restated bylaws, each as amended to date and each as filed or incorporated by reference
as exhibits to our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. For a description of our Common Stock, see
(i) our Registration Statement on Form 8-A, filed with the SEC on October 12, 2021 under Section 12(b) of the Exchange Act, including
any amendments or reports filed for the purpose of updating such description and (ii) Exhibit 4.4—Description of Securities Registered
Pursuant to Section 12 of the Exchange Act, to our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with
the SEC on March 31, 2025.

Our Certificate of Incorporation authorizes the
issuance of up to 2,000,000,000 shares of Common Stock and up to 10,000,000 shares of blank check preferred stock, par value $0.00001
per share, of which 20,000 shares are designated as Series A Super Voting Preferred Stock, and 1,600,000 shares are designated as Series
B Preferred Stock. The Board may establish the rights and preferences of the preferred stock from time to time.

<div align='center'>17

PLAN OF DISTRIBUTION</div>

The Selling Stockholders and any of their pledgees,
assignees and successors-in-interest may, from time